OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Pharmacology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?	108
Editorial Board	100
Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction	92
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling	74
Lipid raft disruption as an opportunity for peripheral analgesia	64
The role of extracellular ATP in homeostatic immune cell migration	59
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies	51
Recent advances in emerging PCOS therapies	50
Gastrointestinal issue: Advances in gastrointestinal oncology	47
Editorial Board	43
Optofluidic neural interfaces for in vivo photopharmacology	40
Technological advancements to study cellular signaling pathways in inherited retinal degenerative diseases	40
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms	37
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma	36
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis	35
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”	33
Advanced microneedle arrays for transdermal antibiotic delivery	33
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance	33
Optic nerve regeneration: Potential treatment approaches	33
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration	33
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury	30
Three-dimensional culture models to study glioblastoma — current trends and future perspectives	30
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis	29
Editorial Board	29
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus	29

Effects of functional electrical stimulation on muscle health after spinal cord injury	28
Allogeneic double-negative T-cell therapy for acute myeloid leukemia	27